Clark Thomas Eugene

SEC source: 0001689126-21-000004 · wf-form4_161480663502421.xml · nonDerivative · entry 1

Clark Thomas Eugene · CIK 0001689126 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,169

F1 · kind: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Systemax Inc. Employee Stock Purchase Plan ("ESPP") on March 3, 2021. This transaction is exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on September 3, 2020.

SEC source: 0001689126-21-000002 · wf-form4_161411622258052.xml · derivative · entry 4

Clark Thomas Eugene · CIK 0001689126 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,350

Underlying: Common Stock · 5,350 shares

Expires 2031-02-21

F4 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on February 21, 2021 have a four year vesting schedule with 1,338 vesting on the first anniversary date of the grant date; 1,338 vesting on the second anniversary date of the grant date; 1,337 vesting on the third anniversary date of the grant date; and 1,337 vesting on the fourth anniversary date of the grant date

SEC source: 0001689126-21-000002 · wf-form4_161411622258052.xml · nonDerivative · entry 3

Clark Thomas Eugene · CIK 0001689126 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,608

F3 · shares: Shares of common stock issued upon vesting of performance-based restricted stock units (subject to deferred delivery) in accordance with the terms of a Performance-based Restricted Stock Unit award originally granted on February 21, 2020.

SEC source: 0001689126-21-000002 · wf-form4_161411622258052.xml · nonDerivative · entry 2

Clark Thomas Eugene · CIK 0001689126 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,165

F2 · shares: Shares surrendered for payment of tax liability incident to vesting of the 2019 Restrictive Award.

SEC source: 0001689126-21-000002 · wf-form4_161411622258052.xml · nonDerivative · entry 1

Clark Thomas Eugene · CIK 0001689126 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,511

F1 · shares: Shares of common stock issued upon vesting of performance-based restricted stock units in accordance with the terms of a Performance-based Restricted Stock Unit award originally granted on January 17, 2019 (the "2019 Restrictive Award").

SEC source: 0001689126-20-000010 · wf-form4_160797991127202.xml · derivative · entry 9

Clark Thomas Eugene · CIK 0001689126 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 4,001 shares

Expires 2026-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on February 1, 2016 have a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001689126-20-000010 · wf-form4_160797991127202.xml · derivative · entry 8

Clark Thomas Eugene · CIK 0001689126 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 10,000 shares

Expires 2026-11-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on November 10, 2016 have a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001689126-20-000010 · wf-form4_160797991127202.xml · nonDerivative · entry 6

Clark Thomas Eugene · CIK 0001689126 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,666

F1 · acquired: This transaction was executed in multiple trades at prices ranging from $36.00 to $36.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001689126-20-000010 · wf-form4_160797991127202.xml · nonDerivative · entry 5

Clark Thomas Eugene · CIK 0001689126 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,667

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001689126-20-000010 · wf-form4_160797991127202.xml · nonDerivative · entry 4

Clark Thomas Eugene · CIK 0001689126 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,666

F1 · acquired: This transaction was executed in multiple trades at prices ranging from $36.00 to $36.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001689126-20-000010 · wf-form4_160797991127202.xml · nonDerivative · entry 3

Clark Thomas Eugene · CIK 0001689126 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001689126-20-000010 · wf-form4_160797991127202.xml · derivative · entry 7

Clark Thomas Eugene · CIK 0001689126 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,501

Underlying: Common Stock · 3,499 shares

Expires 2026-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on February 1, 2016 have a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001689126-20-000010 · wf-form4_160797991127202.xml · nonDerivative · entry 2

Clark Thomas Eugene · CIK 0001689126 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,666

SEC source: 0001689126-20-000010 · wf-form4_160797991127202.xml · nonDerivative · entry 1

Clark Thomas Eugene · CIK 0001689126 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,165

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001689126-20-000008 · wf-form4_159977083692286.xml · nonDerivative · entry 1

Clark Thomas Eugene · CIK 0001689126 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,666

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Systemax Inc. Employee Stock Purchase Plan ("ESPP") on September 2, 2020. This transaction is exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on September 3, 2019.

SEC source: 0001689126-20-000006 · wf-form4_158327372113855.xml · nonDerivative · entry 1

Clark Thomas Eugene · CIK 0001689126 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,233

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Systemax Inc. Employee Stock Purchase Plan ("ESPP") on March 2, 2020. This transaction is exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on September 3, 2019.

SEC source: 0001689126-20-000004 · wf-form4_158154378186017.xml · derivative · entry 3

Clark Thomas Eugene · CIK 0001689126 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,845

Underlying: Common Stock · 9,845 shares

Expires 2030-02-10

F3 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on February 10, 2020 have a four year vesting schedule with: 2,462 of the options vesting on the first anniversary date of the grant date, 2,461 of the options vesting on the second anniversary date of the grant date, 2,461 of the options vesting on the third anniversary date of the grant date and 2,461 of the options vesting on the fourth anniversary date of the grant date.

SEC source: 0001689126-20-000004 · wf-form4_158154378186017.xml · nonDerivative · entry 2

Clark Thomas Eugene · CIK 0001689126 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,820

F2 · shares: Shares surrendered for payment of tax liability incident to vesting of the 2019 Restrictive Award.

SEC source: 0001689126-20-000004 · wf-form4_158154378186017.xml · nonDerivative · entry 1

Clark Thomas Eugene · CIK 0001689126 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,539

F1 · shares: Shares of common stock issued upon vesting of performance-based restricted stock units in accordance with the terms of a Performance-based Restricted Stock Unit award originally granted on January 17, 2019 (the "2019 Restrictive Award").

SEC source: 0001689126-20-000002 · wf-form5_157990481349780.xml · nonDerivative · entry 1

Clark Thomas Eugene · CIK 0001689126 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,708

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Systemax Inc. Employee Stock Purchase Plan ("ESPP") on September 2, 2019. This transaction isexempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 30, 2019.

SEC source: 0001689126-19-000007 · wf-form4_155190794216586.xml · nonDerivative · entry 1

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,130

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Systemax Inc. Employee Stock Purchase Plan ("ESPP") on March 4, 2019. This transaction is exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on March 1, 2019.

SEC source: 0001689126-19-000005 · wf-form4_155026829099000.xml · nonDerivative · entry 1

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,614

F1 · shares: Shares surrendered for payment of tax liability incident to vesting of prior restricted stock award.

SEC source: 0001689126-19-000001 · wf-form4_154816489841616.xml · derivative · entry 5

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,948

Underlying: Common Stock · 24,948 shares

Expires 2029-01-17

F4 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on January 17, 2019 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001689126-19-000001 · wf-form4_154816489841616.xml · derivative · entry 4

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2026-11-10

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F3 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on November 10, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001689126-19-000001 · wf-form4_154816489841616.xml · derivative · entry 3

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 35,000 shares

Expires 2026-11-10

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F3 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on November 10, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001689126-19-000001 · wf-form4_154816489841616.xml · derivative · entry 2

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2026-02-01

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F2 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on February 1, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001689126-19-000001 · wf-form4_154816489841616.xml · derivative · entry 1

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2026-02-01

F1 · kind: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on January 17, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Employee Stock Option (right to buy) has been amended to reduce such exercise price by $2.30. There have been no other changes to the terms of the Employee Stock Option (right to buy). The Option Repricing was related to a special dividend declared in December 2018.

F2 · derivative.exercise_date: The Employee Stock Option (right to buy) granted on February 1, 2016 had a four year vesting schedule with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.

SEC source: 0001689126-19-000002 · wf-form5_154816500928540.xml · nonDerivative · entry 1

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,534

F1 · shares: Shares surrendered for payment of tax liability incident to vesting of prior restricted stock award.

F2 · balance_after: The amount of non-derivative securities beneficially owned as of the date of the filing of this Form 5 is 18,534, which includes 8,333 unvested Restricted Stock Units that were granted on February 1, 2016 and 10,201 shares of common stock.

SEC source: 0001689126-18-000009 · wf-form4_154508153874080.xml · derivative · entry 3

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 15,000 shares

Expires 2026-11-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Cashless exercise of 15,000 options and immediate sale of 15,000 shares of common stock through broker of an award granted on November 10, 2016.

F4 · derivative.exercise_date: The options vest over a period of four years with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date, which is November 10, 2016.

SEC source: 0001689126-18-000009 · wf-form4_154508153874080.xml · nonDerivative · entry 2

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,534

F1 · kind: Cashless exercise of 15,000 options and immediate sale of 15,000 shares of common stock through broker of an award granted on November 10, 2016.

F2 · price: This transaction was executed in multiple trades at prices ranging from $31.00 to $31.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: The amount of non-derivative securities beneficially owned following the transaction on Table I is 18,534, which includes 8,333 unvested Restricted Stock Units that were granted on February 1, 2016 and 10,201 shares of common stock.

SEC source: 0001689126-18-000009 · wf-form4_154508153874080.xml · nonDerivative · entry 1

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,534

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Cashless exercise of 15,000 options and immediate sale of 15,000 shares of common stock through broker of an award granted on November 10, 2016.

SEC source: 0001689126-18-000003 · wf-form4_153367819837280.xml · derivative · entry 6

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2022-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Pursuant to the previously disclosed share repurchase program, the Issuer has entered into, with the approval of the Board of Directors, a privately negotiated, arm's length agreement with the filing person to repurchase an aggregate of 10,000 shares (by means of a net cashless exercise of options and net of applicable taxes) at a price equal to $38.96 per share, reflecting a 4% discount to the closing price of the Issuer's common stock on August 2, 2018. 7,214 of such shares were surrendered to the Issuer to satisfy the exercise price of each of the stock options and to satisfy withholding tax obligations and 2,786 of such shares were purchased by the Issuer pursuant to Rule 16b-3(e).

F4 · derivative.exercise_date: The options vest over a period of four years with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date, which is March 1, 2012.

SEC source: 0001689126-18-000003 · wf-form4_153367819837280.xml · derivative · entry 5

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2020-08-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Pursuant to the previously disclosed share repurchase program, the Issuer has entered into, with the approval of the Board of Directors, a privately negotiated, arm's length agreement with the filing person to repurchase an aggregate of 10,000 shares (by means of a net cashless exercise of options and net of applicable taxes) at a price equal to $38.96 per share, reflecting a 4% discount to the closing price of the Issuer's common stock on August 2, 2018. 7,214 of such shares were surrendered to the Issuer to satisfy the exercise price of each of the stock options and to satisfy withholding tax obligations and 2,786 of such shares were purchased by the Issuer pursuant to Rule 16b-3(e).

F3 · derivative.exercise_date: The options vest over a period of four years with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date, which is August 9, 2010.

SEC source: 0001689126-18-000003 · wf-form4_153367819837280.xml · nonDerivative · entry 4

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,534

F1 · kind: Pursuant to the previously disclosed share repurchase program, the Issuer has entered into, with the approval of the Board of Directors, a privately negotiated, arm's length agreement with the filing person to repurchase an aggregate of 10,000 shares (by means of a net cashless exercise of options and net of applicable taxes) at a price equal to $38.96 per share, reflecting a 4% discount to the closing price of the Issuer's common stock on August 2, 2018. 7,214 of such shares were surrendered to the Issuer to satisfy the exercise price of each of the stock options and to satisfy withholding tax obligations and 2,786 of such shares were purchased by the Issuer pursuant to Rule 16b-3(e).

F2 · balance_after: The amount of non-derivative securities beneficially owned following the transaction on Table I is 18,534, which includes 8,333 unvested Restricted Stock Units that were granted on February 1, 2016 and 10,201 shares of common stock.

SEC source: 0001689126-18-000003 · wf-form4_153367819837280.xml · nonDerivative · entry 3

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,534

F1 · kind: Pursuant to the previously disclosed share repurchase program, the Issuer has entered into, with the approval of the Board of Directors, a privately negotiated, arm's length agreement with the filing person to repurchase an aggregate of 10,000 shares (by means of a net cashless exercise of options and net of applicable taxes) at a price equal to $38.96 per share, reflecting a 4% discount to the closing price of the Issuer's common stock on August 2, 2018. 7,214 of such shares were surrendered to the Issuer to satisfy the exercise price of each of the stock options and to satisfy withholding tax obligations and 2,786 of such shares were purchased by the Issuer pursuant to Rule 16b-3(e).

F2 · balance_after: The amount of non-derivative securities beneficially owned following the transaction on Table I is 18,534, which includes 8,333 unvested Restricted Stock Units that were granted on February 1, 2016 and 10,201 shares of common stock.

SEC source: 0001689126-18-000003 · wf-form4_153367819837280.xml · nonDerivative · entry 2

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,534

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Pursuant to the previously disclosed share repurchase program, the Issuer has entered into, with the approval of the Board of Directors, a privately negotiated, arm's length agreement with the filing person to repurchase an aggregate of 10,000 shares (by means of a net cashless exercise of options and net of applicable taxes) at a price equal to $38.96 per share, reflecting a 4% discount to the closing price of the Issuer's common stock on August 2, 2018. 7,214 of such shares were surrendered to the Issuer to satisfy the exercise price of each of the stock options and to satisfy withholding tax obligations and 2,786 of such shares were purchased by the Issuer pursuant to Rule 16b-3(e).

F2 · balance_after: The amount of non-derivative securities beneficially owned following the transaction on Table I is 18,534, which includes 8,333 unvested Restricted Stock Units that were granted on February 1, 2016 and 10,201 shares of common stock.

SEC source: 0001689126-18-000003 · wf-form4_153367819837280.xml · nonDerivative · entry 1

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,534

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Pursuant to the previously disclosed share repurchase program, the Issuer has entered into, with the approval of the Board of Directors, a privately negotiated, arm's length agreement with the filing person to repurchase an aggregate of 10,000 shares (by means of a net cashless exercise of options and net of applicable taxes) at a price equal to $38.96 per share, reflecting a 4% discount to the closing price of the Issuer's common stock on August 2, 2018. 7,214 of such shares were surrendered to the Issuer to satisfy the exercise price of each of the stock options and to satisfy withholding tax obligations and 2,786 of such shares were purchased by the Issuer pursuant to Rule 16b-3(e).

F2 · balance_after: The amount of non-derivative securities beneficially owned following the transaction on Table I is 18,534, which includes 8,333 unvested Restricted Stock Units that were granted on February 1, 2016 and 10,201 shares of common stock.

SEC source: 0001628280-18-001604 · wf-form5_151856684847388.xml · nonDerivative · entry 1

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,477

F1 · shares: Shares surrendered to the Issuer for payment of tax liability incident to vesting of prior restricted stock award.

F2 · balance_after: The amount of non-derivative securities beneficially owned at the end of Issuer's fiscal year is 21,477, which includes the February 1, 2016 grant of 25,000 Restricted Stock Units (16,666 remain unvested) and 4,811 shares of common stock.

SEC source: 0001140361-16-086363 · form4.xml · derivative · entry 1

Clark Thomas Eugene · CIK 0001689126 · Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2026-11-10

F1 · derivative.exercise_date: The options vest over a period of four years with 25% of the options vesting on the first, second, third and fourth anniversary dates of the grant date.